EventsThe 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Event submissions
Published
This submission belongs to the session S4. New Small molecules as drug candidates of the event The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published date
29 Oct, 2025
Academic Editor
author-avatarThierry Besson
Citation
Marya Júlya da Silva Santos Lugão, Victor Hugo Menezes Costa, Pâmella Cordeiro, Maria Eduarda Ribeiro da Rocha, Paloma Taborda Birmann, Cristiani Folharini Bortolatto, César Augusto Bruning, Vanessa Nascimento, Selenocyanate Derivatives as Acetylcholinesterase Inhibitors: Potential Therapeutic Agents for Alzheimer’s Disease, in Proceedings of The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics, 1 November–30 November 2025, MDPI: Basel, Switzerland
Share
Email
FaceBook
Twitter
Linkedin

Selenocyanate Derivatives as Acetylcholinesterase Inhibitors: Potential Therapeutic Agents for Alzheimer’s Disease

Marya Júlya da Silva Santos Lugão 1
image
Victor Hugo Menezes Costa 1
Pâmella Cordeiro 2
Maria Eduarda Ribeiro da Rocha 3
Paloma Taborda Birmann 3
Cristiani Folharini Bortolatto 3
César Augusto Bruning 3
image
Vanessa Nascimento 1
1. SupraSelen Laboratory, Department of Organic Chemistry, Institute of Chemistry, Fluminense Federal University (UFF), São João Batista Street, Niterói, RJ, 24020-007, Brazil
2. Federal University of Santa Catarina (UFSC), Florianópolis, SC, 88040-900, Brazil
3. Laboratory of Biochemistry and Molecular Neuropharmacology (LABIONEM), Graduate Program in Biochemistry and Bioprospecting (PPGBBio), Chemical, Pharmaceutical, and Food Sciences Center (CCQFA), Federal University of Pelotas (UFPel), Capão do Leão, Brazil
Abstract
Keywords
Neurodegenerative diseases
enzyme inhibition
selenocyanates
organoselenium
in vitro
brain